Carregant...
Targeting Therapy to The Neuromuscular Junction: Proof of Concept
INTRODUCTION: The site of pathology in myasthenia gravis (MG) is the neuromuscular junction (NMJ). Our goal was to determine the ability to direct complement inhibition to the NMJ. Methods: A single-chain antibody directed against the alpha subunit of the acetylcholine receptor was synthesized (scFv...
Guardat en:
| Publicat a: | Muscle Nerve |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BlackWell Publishing Ltd
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4296224/ https://ncbi.nlm.nih.gov/pubmed/24037951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mus.24057 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|